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AbstrACt
Objectives The number of older people is growing across 
the world; however, quantitative synthesis of studies 
examining the impact of lifestyle factors on the ageing 
process is rare. We conducted a systematic review and 
meta-analysis of longitudinal studies to synthesise the 
associations of smoking and alcohol consumption with 
healthy ageing (HA).
Methods Major electronic databases were searched 
from inception to March 2017 (prospectively 
registered systematic reviews registration number 
CRD42016038130). Studies were assessed for 
methodological quality. Random-effect meta-analysis was 
performed to calculate pooled ORs and 95% CI.
results In total, we identified 28 studies (n=184 543); 
27 studies reported results on smoking, 22 on alcohol 
consumption. 23 studies reported a significant positive 
association of never or former smoking with HA and 
4 non-significant. 12 studies reported a significant 
positive association of alcohol consumption with HA, 9 
no association and 1 negative. Meta-analysis revealed 
increased pooled OR of HA for never smokers compared 
with current smokers (2.36, 95% CI 2.03 to 2.75), never 
smokers compared with former smokers (1.32, 95% CI 
1.23 to 1.41), former or never smokers compared with 
current smokers (1.72, 95% CI 1.20 to 2.47), never 
smokers compared with past or current smokers (1.29, 
95% CI 1.16 to 1.43); drinkers compared with non-drinkers 
(1.28, 95% CI 1.08 to 1.52), light drinkers compared 
with non-drinkers (1.12, 95% CI 1.03 to 1.22), moderate 
drinkers compared with non-drinkers (1.35, 95% CI 0.93 
to 1.97) and high drinkers compared with non-drinkers 
(1.25, 95% CI 1.09 to 1.44). There was considerable 
heterogeneity in the definition and measurement of HA and 
alcohol consumption.
Conclusions There is consistent evidence from 
longitudinal studies that smoking is negatively associated 
with HA. The associations of alcohol consumption with 
HA are equivocal. Future research should focus on the 
implementation of a single metric of HA, on the use of 
consistent drinking assessment among studies and on a 
full-range of confounding adjustment. Our research also 
highlighted the limited research on ageing in low-and-
middle-income countries.
IntrOduCtIOn 
Smoking has emerged as the leading contrib-
uting factor of many respiratory diseases and 
one of the most important risk factors for 
cardiovascular diseases, cancers of several 
organs and many other pathological condi-
tions.1 In systematic reviews focusing on 
older people, smoking is associated with 
premature mortality2 and an increased inci-
dence of Alzheimer’s disease.3 Smoking is 
also linked with a considerable societal cost 
as smoking-related absenteeism and prema-
ture deaths create an additional burden to 
the healthcare system and to the economy in 
general.4 The healthcare cost of tobacco-re-
lated diseases accounted for almost 6% of the 
global health expenditures in 2012.5 
Tobacco use and harmful use of alcohol 
are recognised by the United Nations Polit-
ical Declaration on Non-Communicable 
Diseases among the most common risk 
strengths and limitations of this study
 ► This is the first systematic review and meta-analysis 
trying to quantify the associations of smoking and 
alcohol consumption with healthy ageing; our find-
ings were also adjusted for publication bias.
 ► Independent double screening, searching of previ-
ous systematic reviews in the field and the reference 
lists of the eligible studies as well as not excluding 
non-English studies guarantee that limited number 
of studies may not have been considered.
 ► Heterogeneity in the definition and measurement of 
healthy ageing as well as different confounding ad-
justment in the initial studies may have influenced 
our meta-analytical results.
 ► The number of studies included in the meta-analy-
sis regarding the associations of alcohol consump-
tion was small due to the great heterogeneity in its 
measurement.
 ► Our findings may not be generalisable due to the lim-
ited research in low-and-middle-income countries.
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factors.6 Harmful use of alcohol results in approximately 
3.3 million deaths annually (5.9% of all deaths) and alco-
hol-attributable deaths are the highest for middle-aged 
people.7 Older people’s sensitivity to the effects of alcohol 
increases whereas tolerance decreases,8 meaning that even 
a low amount of alcohol can create problems in an older 
person. In addition, older people who drink harmfully 
often do not present to services due to stigma associated 
with harmful drinking, and when they do, their symptoms 
can be easily confused with physical and mental issues 
associated with ageing.9 Nevertheless, studies showed that 
light to moderate alcohol consumption is associated with 
a decreased risk in dementia,10 as well as with a reduced 
risk for cardiovascular disease mortality, incident coro-
nary heart disease, incident stroke, stroke mortality and 
all-cause mortality.11
Drinking and smoking are correlated in the general 
population12 with smokers being more likely to drink 
and vice versa.13 People who are smokers and heavy 
drinkers exhibit the highest mortality rate as indicated 
in a study of middle-aged male participants14; another 
study also showed that men who smoked and drank >15 
units per week of alcohol had almost three times higher 
all-cause mortality rate compared with non-smokers and 
non-drinkers.15 As populations are ageing rapidly, with 
one in eight people currently aged ≥60 and with these 
estimates predicted to increase,16 it is critical to under-
stand the factors that will enable people to live longer and 
age in a healthy way.
To address the need for more accurate estimates of the 
relationship between smoking and healthy ageing and 
alcohol consumption and healthy ageing, we conducted 
a systematic review and meta-analysis of longitudinal 
studies which examined the associations of these factors 
with the ageing process.
MethOds
search strategy and selection criteria
This systematic review has been written following the 
Preferred Reporting Items for a Systematic Review and 
Meta-Analysis (PRISMA) and the guidelines for Meta-Anal-
yses Of Observational Studies in Epidemiology to ensure 
accuracy and comprehensiveness.17 18 (online supple-
mentary appendix 1). A review protocol was prospectively 
registered in the international database of prospectively 
registered systematic reviews under registration number 
CRD42016038130 (online supplementary appendix 2). 
As part of a larger body of work considering modifiable 
lifestyle factors and healthy ageing, we originally planned 
to carry out a review focusing on the following: physical 
activity, smoking and alcohol consumption. The current 
systematic review specifically focuses on the findings 
related to smoking, alcohol consumption and healthy 
ageing outcomes since a sufficient amount of literature 
was identified on this topic alone. Our findings regarding 
healthy ageing and physical activity have been presented 
elsewhere.19
Two authors (CD, CK) searched MEDLINE (PubMed/
PubMed Central interface), EMBASE (OVID interface), 
PsycINFO (OVID interface) and CENTRAL from incep-
tion up to April 2016. Searching methodology included 
any related term or synonym to healthy ageing and text 
word related to physical activity, smoking and alcohol 
consumption (online supplementary appendix 3). 
Other relevant systematic reviews and reference lists of 
the eligible studies were also searched. Finally, a second 
search was performed on 15th March 2017 to include 
studies that were recently published.
Eligible studies had to meet the following criteria: 
(i) being published in an electronic journal article, (ii) 
constitute an original peer-reviewed longitudinal study 
and (iii) report any kind of longitudinal association 
between smoking and/or alcohol consumption and 
healthy ageing. Data on smoking and alcohol, through 
self-report and/or specific questionnaires, referred either 
to the current status and/or across the life span. The 
primary outcome of this review was health status measured 
by healthy ageing and any other term related to it (eg, 
successful ageing, active ageing, healthy survival). Studies 
whose primary goal was the examination of a different 
determinant but included the aforementioned factors as 
covariates were also included. Due to the heterogeneity 
of the healthy ageing definition, studies reporting the 
latter as multiple outcomes or based solely on self-report 
were excluded. Studies that included cohorts of individ-
uals who were institutionalised or hospitalised and animal 
studies were also excluded. No language restriction was 
applied.
In order to store the studies that were retrieved by 
the electronic search, we used an EndNote (ENDNOTE 
X7, Thomson Reuters) library. After removal of dupli-
cates, the two independent reviewers screened titles and 
abstracts of all potentially eligible papers. At the end of 
this procedure, any disagreement was solved by discus-
sion. In case that an agreement could not be achieved, 
eligibility of the study was judged by discussion with a 
third senior researcher (AMP). In case that full text could 
not be retrieved, the corresponding author of the paper 
was contacted via email.
data extraction and quality assessment
CD and CK independently extracted data from each 
study and a random sample of them was cross-checked by 
AMP. Setting/country of the study, data collection period, 
follow-up year, sample size, population and baseline age 
information was recorded for each study. Definition and 
measurement of the healthy ageing outcome, of smoking 
and alcohol consumption, were also recorded, as well as 
the Odds Ratios (ORs) or any other related statistic and 
the 95% confidence intervals (CIs). Reported statistics 
were extracted for the least and most adjusted models 
reported in the study.
The methodological quality of the included studies 
was assessed by using the Quality in Prognosis Studies 
(QUIPS) tool. QUIPS evaluates six potential components 
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of bias: inclusion, attrition, prognostic factor measure-
ment, confounders, outcome measurement, and analysis 
and reporting.20 During the application of the QUIPS 
tool, smoking and/or alcohol consumption were consid-
ered as the only prognostic factors and all other variables, 
used as explanatory variables of the model, were consid-
ered as confounders. Since we included only longitudinal 
studies, the existence of attrition was expected. In the 
scenario that the attrition rate was high, authors’ expla-
nations were required to evaluate the study as bearing low 
risk of bias. Finally, the reliability of statistical models was 
evaluated according to the data presented; for instance, 
the reliability of studies that included results only for the 
statistically significant factors was judged with caution.
Patient and public involvement
No patients were involved in this study. We used data from 
published papers only.
data analysis
We performed meta-analyses in order to produce a pooled 
effect size estimate for the relationship between smoking 
and healthy ageing and alcohol consumption and healthy 
ageing. Separate meta-analyses were performed for the 
following categories.
Smoking
(i) Past and never smokers compared with current smokers, 
(ii) former or never smokers compared with current 
smokers and (iii) never smokers compared with former 
or current smokers.
Alcohol
For studies that provided alcohol quantities, we converted 
grams to drinks by assuming that 12 g of alcohol is 
approximately one drink to have an alcohol consump-
tion variable comparable among studies.21 In studies that 
provided alcohol consumption in an interval, we took the 
middle of the interval as the most likely value. We created 
the following categories: light (<1 drink/day), moderate 
(1–2 drinks/day) and high (>2–4 drinks/day) consump-
tion that were compared with never drinkers. Studies that 
did not report specific alcohol quantity but characterised 
the participants as drinkers or non-drinkers were exam-
ined separately.
We produced pooled effect estimates of the aforemen-
tioned categories for the most adjusted models. Due to 
the expected heterogeneity, a random-effects meta-anal-
ysis using the DerSimonian-Laird model was performed.22 
If a study reported different results for men and women, 
both results were included, except in cases where a result 
for the mixed population was also provided; the same 
rationale was applied to cases that reported statistics per 
different subgroups in the cohort. We also investigated via 
subgroup analyses the effect of baseline age (ie, studies 
with baseline mean age >65 years and studies with baseline 
mean age ≤65 years) and follow-up time (ie, studies with 
follow-up time >10 years and studies with follow-up time 
≤10 years) to the pooled effect estimates. Heterogeneity 
was assessed with I2 statistic for each analysis,23 and publi-
cation bias24 was assessed with Egger bias test.25 Finally, a 
trim-and-fill adjusted analysis was conducted to adjust for 
potential publication bias.26 Analyses were performed in 
STATA V.14 IC.
results
The search identified 6706 papers from the databases 
and 30 additional papers were obtained from other 
sources. After removing of duplicates and of papers that 
were conference papers, cross-sectional studies or animal 
studies, 73 papers were considered for full-text review. We 
excluded 42 papers based on specific reasons after full-
text review and finally 28 studies were included in this 
report.27–54 PRISMA flow diagram depicts the exact selec-
tion process figure 1. Across the 28 eligible studies, there 
were 184 543 participants (almost 31% men), with sample 
size ranging from 456 to 68 153. Studies were published 
from 1989 to 2016 and half of them (14 out of 28) took 
place in the USA. Studies were also conducted in England 
(four), Australia (three), China (two), Canada (two), 
Nigeria (one), the Netherlands (one) and Taiwan (one). 
Baseline age ranged from 14 to 109 years and follow-up 
time from 2 years until death (>70 years). Five studies 
examined men only and two studies examined women 
only; the majority of studies reported results for mixed 
populations (table 1).
Healthy ageing, and any other term used as a synonym, 
was defined by including various domains of informa-
tion in each study. These were grouped in the following 
categories: survival to a specific age or during follow-up, 
health status (either self-reported or measured by specific 
questionnaires), physical performance (including infor-
mation regarding mobility, disabilities and/or difficulties 
in activities of daily living and instrumental activities of 
daily living), diseases (including chronic diseases and 
cancer), mental health and cognition status, subjec-
tive measurements of the participants (life satisfac-
tion, happiness and pain) and other (anthropometric 
measurements, personal assistance, social support) 
(figure 2). Most of the studies (23 out of 28) included 
physical performance in their definition of healthy 
ageing and more than half of them included informa-
tion regarding diseases and mental health (18 and 16 
out of 28, respectively). Survival to a specific age was also 
an area often found in the definition of healthy ageing, 
whereas health status and subjective measurements were 
not so often included. (Online supplementary table A1 
presents the areas of information included in the defini-
tion of healthy ageing per study.)
In table 2, the analytical results of this systematic review 
are presented. Relevant statistics per study are provided 
for every group of smoking and alcohol consumption 
variable and for the most and least adjusted models; 
confounders used for the final adjustment are also 
provided.
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Quality assessment
Of the 28 studies, 1 was evaluated as having high risk of 
bias, 9 as moderate and 18 as having low. In aggregate, 
the quality of the included studies was above moderate. 
As it was expected, attrition and confounding were the 
issues that primarily contributed to moderate and high 
bias. Specifically, 18 out of 28 studies reported moderate 
or high risk of bias regarding the fact that the popula-
tion lost to follow-up may be associated with key charac-
teristics that could influence the observed relationship 
between outcome and factors. Similar results were also 
observed for the confounders’ domain, where 18 out of 
23 studies were characterised as having moderate risk of 
bias, meaning that important confounders may have not 
been appropriately accounted in the final model (online 
supplementary table A2).
Meta-analysis
Smoking and healthy ageing
From the 27 studies providing results for smoking, we did 
a meta-analysis with 18 studies. We excluded studies that 
provided results using (i) healthy/successful years,30 42 (ii) 
risk ratio,40 (iii) coefficients from linear mixed models 
or generalised estimation equation models41 50 and (iv) 
cigarette packs.45 52 53 All studies included in the meta-anal-
ysis were of moderate and low risk of bias.
Never smokers compared with current smokers had 
more than double increased odds of ageing healthily 
(OR 2.36, 95% CI 2.03 to 2.75, I2 43.30%, 7 studies) even 
after adjusting for publication bias with the trim-and-fill 
algorithm (OR 2.11, 95% CI 1.82 to 2.45, 10 studies). 
Never smokers had increased ORs compared with former 
smokers as well (OR 1.32, 95% CI 1.23 to 1.41, I2 32.80%, 
five studies); no change of the combined effect estimate 
was observed by the trim-and-fill method. Never smokers 
were more likely to experience healthy ageing than 
current or former smokers (OR 1.29, 95% CI 1.16 to 1.43, 
I2 0.00%, five studies), and this finding marginally altered 
when we adjusted for publication bias (OR 1.27, 95% CI 
1.14 to 1.40, nine studies). Never or former smokers were 
more likely to age in a healthy way compared with current 
smokers (OR 1.72, 95% CI 1.20 to 2.47, I2 87.20%, six 
studies); however, when we adjusted for publication bias 
this finding was no longer significant (OR 1.20, 95% CI 
0.83 to 1.73, nine studies).
There were also two studies that reported HRs47 48; 
the pooled HR of never smokers compared with current 
smokers was 1.55 (95% CI 1.18 to 2.02) while the pooled 
Figure 1 Selection process.
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Table 1 Baseline characteristics of the eligible studies
Studies/authors Country Panel
Data collection 
period
Follow-
up (years)*
Sample 
size Gender
Baseline 
age (years)
Andrews et al27 Australia Australian Longitudinal 
Study of Aging 
1992 8 1403 55% 
men
>70
Bell et al28 USA Honolulu Heart Program 1991–1993 Up to 
21 years
1292 100% 
men
71–82
Britton et al29 England Whitehall II study 1985–1988 17 5823 71% 
men
35–55
Burke et al30 USA Cardiovascular Health 
Study 
1989–1990, 
1992–1993
6.5 and 3.5 3342 39% 
men
>65
Ford et al31 USA N/A 1993 2 602 33% 
men
>70
Gu et al32 China Chinese Longitudinal 
Healthy Longevity Survey 
2002 3 15 972 45% 
men
65–109
Guralnik and Kaplan33 USA Alameda County Study 1965 19 841 N/A 46–70
Gureje et al34 Nigeria Ibadan Study of Ageing August 2003 to 
November 2004
5.3 930 61% 
men
>65
Hamer et al35 England English Longitudinal Study 
of Ageing 
2002–2003 8 3454 42% 
men
63.7 (M)
Hodge et al36 Australia Melbourne Collaborative 
Cohort Study
1990–1994 11.7 5512 37% 
men
63 (M)
Hodge et al 37 Australia Melbourne Collaborative 
Cohort Study
1990–1994 11.1 (WM) 6309 39% 
men
64.1 (WM)
Kaplan et al 38 Canada Canadian National 
Population Health Survey 
1994–1995 10 2432 44% 
men
65–85
LaCroix et al39 USA Women’s Health Initiative 1993–1998 16 68 153 100% 
women
68.9 (WM)
Li et al40 China Shanghai Mental Health 
Center
1987 5 3024 43% 
men
67.3 (M)
Liu and Su41 Taiwan Taiwan Longitudinal Study 
on Aging 
1993 14 3155 56% 
men
71.7 (M)
Newman et al42 USA Cardiovascular Health 
Study 
1989–1990, 
1992–1993
8 2932 39% 
men
71.9 (WM)
Newson et al43 Netherlands Rotterdam Study 1990–1993 7.9 2008 34% 
men
75.8 (M)
Pruchno and Wilson-
Genderson44
USA Ongoing Research on 
Aging in New Jersey: 
Bettering Opportunities for 
Wellness in Life
2006–2008 4 2614 37% 
men
60.5 (WM)
Reed et al45 USA Honolulu Heart Program 1965–1968 28 8006 100% 
men
45–68
Sabia et al46 England Whitehall II study 1991–1994 >16.3 (med) 5100 70% 
men
51.3 (M)
Sarnak et al47 USA Cardiovascular Health 
Study 
1989–1990 and 
1992–1993 
(African-American 
cohort)
4.3 2140 38% 
men
74
Shields and Martel48 Canada National Population Health 
Survey 
1994–1995 8 1309 N/A >65
Sun et al49 USA Nurses’ Health Study 1980–1986 20 and 16 13 894 100% 
women
58 (med)
Tampubolon50 England English Longitudinal Study 
of Ageing 
2004 9 14 765 46% 
men
50–89
Terry et al51 USA Framingham Heart Study 1948–1971 45 2531 44% 
men
40–50
Continued
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HR of former smokers compared with never smokers was 
1.30 (95% CI 1.07 to 1.59). Egger test was not significant 
in any analysis that we performed (p value>0.05), hence 
no evidence for publication bias was provided (table 3). 
The synthesis of the results is provided in figure 3.
Subgroup analysis
Baseline age
The association of smoking with healthy ageing did not 
change direction or strength in the subgroup analyses. 
However, the beneficial association of non-smoking was 
higher in studies with baseline mean age <65 years. The 
only association that differed was that in the analysis of 
former or never compared with current smokers. Studies 
with relatively older participants showed a non-signifi-
cant association (OR 1.34, 95% CI 0.65 to 2.76), whereas 
studies with relatively younger participants showed a 
statistically significant association (OR 1.90, 95% CI 1.51 
to 2.40) (online supplementary figure A1).
Follow-up time
We performed subgroup analyses for former or never 
versus current smokers and never versus former or 
current smokers; all other groups had follow-up time 
>10 years. In the group of former or never smokers 
compared with current smokers, the association was not 
significant in studies with <10 years follow-up (OR 1.41, 
95% CI 0.99 to 2.01). No considerable differences were 
observed in the group of never compared with former 
or current smoking with healthy ageing (online supple-
mentary figure A2).
Alcohol consumption and healthy ageing
From the 21 studies that provided statistics for the asso-
ciation of alcohol consumption with healthy ageing, 
we performed meta-analyses using nine studies. We 
excluded studies for the following reasons: (i) the 
standardisation of alcohol consumption was not 
possible28 38 40 44 46 48 52–54 and (ii) they provided healthy 
years30 or β coefficients.41 50
Drinkers compared with non-drinkers had increased 
odds of ageing healthily (OR 1.28, 95% CI 1.08 to 1.52, 
I2 72.10%, five studies); the same beneficial association 
of alcohol was also observed when we pooled results 
among studies that reported findings of light consump-
tion (<1 drinker per day) and moderate consumption 
(1–2 drinks per day) compared with non-drinkers: 
(OR 1.12, 95% CI 1.03 to 1.22, I2 0.00%, three studies); 
(OR 1.35, 95% CI 0.93 to 1.97, I2 71.40%, four studies). 
However, in the latter comparison (ie, moderate 
consumption compared with non-drinkers) results 
were not statistically significant (p value 0.112). We also 
pooled results of the studies reporting high (>2–4 drinks 
per day) consumption compared with non-drinkers; 
(OR 1.25, 95% CI 1.09 to 1.44, I2  0.00%, three studies). 
Results changed when we used the trim-and-fill algo-
rithm only to the case of moderate to non-drinkers 
(OR 1.10, 95% CI 0.77 to 1.57, six studies). Egger test of 
bias was significant only in the analysis of light drinkers 
(p value 0.043) (table 3). The synthesis of the results is 
provided in figure 4.
Studies/authors Country Panel
Data collection 
period
Follow-
up (years)*
Sample 
size Gender
Baseline 
age (years)
Vaillant and 
Mukamal52
USA Study of Adult 
Development at Harvard 
University
Circa 1940 Until 60 or 
death
724 100% 
men
Born 
mainly in 
the 1920s
Vaillant and Western53 USA Study of Adult 
Development
1940–1945 60 (until 
70 years or 
death)
456 100% 
men
14
Willcox et al54 USA Honolulu Heart Program/
Honolulu Asia Aging Study 
1965–1968 40 5820 100% 
men
54 (WM)
*Mean years, unless otherwise specified.
M, mean; med, median; N/A, not available; WM, weighted mean.
Table 1 Continued 
Figure 2 Areas of information included in the definition of 
healthy ageing.
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Subgroup analysis
Baseline age
We could not perform subgroup analyses for the asso-
ciations of alcohol consumption with healthy ageing as 
studies were homogeneous.
Follow-up time
We performed subgroup analysis for drinkers versus 
non-drinkers; all other groups were homogeneous (ie, 
>10 years). The association of alcohol consumption with 
healthy ageing was significantly positive in studies with 
follow-up time >10 years (OR 1.41, 95% CI 1.36 to 1.48), 
whereas studies with follow-up time <10 years showed a 
non-significant beneficial association (OR 1.09, 95% CI 
0.95 to 1.24) (online supplementary figure A3).
dIsCussIOn
Based on our knowledge, this is the first systematic review 
to examine the association of smoking and alcohol 
consumption with healthy ageing, which included a 
meta-analysis to produce a pooled effect estimate and also 
examined eligible studies for publication bias. In total, 23 
out of 27 studies reported a positive association between 
never or former smoking and healthy ageing and four 
reported a non-significant relationship. With regards to 
alcohol consumption, results were mixed but a positive 
association of drinking with healthy ageing was reported 
in 12 out of 22 studies. Nine studies did not find an asso-
ciation and one study reported a negative one.
The current systematic review adds to the plethora of 
evidence that smoking is associated with worse health 
outcomes in older age. In fact, the only study that 
reported a positive association between current smoking 
and healthy ageing was that of Li et al40 where smokers 
exhibit increased risk ratios of healthy survival (RR 
1.11, 95% CI 1.01 to 1.21); however, the authors recom-
mend to treat this finding with caution as the popula-
tion-attributable percentage is very low after 5 years of 
follow-up (2.55%). In aggregate, being a non-smoker 
or a former smoker increases considerably the odds of 
ageing healthily. From our meta-analysis, we found that 
never smokers have more than double the odds of expe-
riencing healthy ageing (OR 2.36, 95% CI 2.03 to 2.75) 
compared with current smokers. Furthermore, never 
smokers are also more likely to age in a healthy way by 
>30% (OR 1.32, 95% CI 1.23 to 1.41) compared with 
former smokers. These findings indicate that smoking 
cessation is always beneficial and comes in accordance 
with a 50-year study on doctors’ mortality in relation with 
smoking. In this study, it was revealed that smoking cessa-
tion at age 60, 50, 40 or 30 years could increase life expec-
tancy by 3, 6, 9 or 10 years, respectively.55 Our findings 
also confirm previous research examining the beneficial 
effect of non-smoking on successful ageing.56 In addition, 
we found that never/former smokers compared with 
current smokers have an increased likelihood of healthy 
ageing (OR 1.72, 95% CI 1.20 to 2.47), which becomes A
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non-significant when we adjust for publication bias (OR 
1.20, 95% CI 0.83 to 1.73). This comes in agreement with 
the finding of a study examining the transitions within 
smoking categories and successful ageing, where former 
compared with current smokers cannot predict successful 
ageing.57
Positive associations between drinking and healthy 
ageing refer to limited alcohol consumptions; for 
Table 3 Results of meta-analysis: healthy ageing compared with smoking and alcohol consumption
Analysis
 Studies
(n) ORs and 95% CI P values I2 (%)
Egger bias;
P values
Trim-and-fill
ORs and 95% CI
Filled 
studies (n)
Never vs current smokers 7* 2.36 (2.03 to2.75) <0.001 43.3 1.42; 0.060 2.11 (1.82 to 2.45) 10
Never vs former smokers 5† 1.32 (1.23 to 1.41) <0.001 32.8 −0.09; 0.935 Unchanged – 
Past/never vs current 6‡ 1.72 (1.20 to 2.47) 0.003 87.2 3.55; 0.142 1.20 (0.83 to 1.73) 9
Never vs past/current 5§ 1.29 (1.16 to 1.43) <0.001 0.0 1.08; 0.157 1.27 (1.14 to 1.40) 9
Drinkers vs non-drinkers 5¶ 1.28 (1.08 to 1.52) 0.004 72.1 −1.25; 0.350 Unchanged – 
Light vs non-drinkers 3** 1.12 (1.03 to 1.22) 0.010 0.0 −8.17; 0.043 Unchanged – 
Moderate vs non-drinkers 4†† 1.35 (0.93 to 1.97) 0.112 71.4 1.77; 0.549 1.10 (0.77 to 1.57) 6
High to non-drinkers 3‡‡ 1.25 (1.09 to 1.44) 0.002 0.0 −0.63; 0.828 Unchanged – 
*Bell et al28; Britton et al (males)29; Britton et al (females)29; Hodgeet al36; Hodge et al37; LaCroix et al (veterans)39; LaCroix et al (non-
veterans).39
†Bell et al28; Hodgeet al36; Hodge et al37; LaCroix et al (veterans)39; LaCroix et al (non-veterans).39
‡Ford et al31; Gu et al32; Guralnik and Kaplan 33; Hamer et al35; Pruchno and Wilson-Genderson44; Terry et al.51
§Kaplan et al38; Newson et al43; Gureje et al34; Sabia et al46; Willcox et al.54
¶Ford et al31; Gu et al32; Gureje et al34; LaCroix et al (veterans)39; LaCroix et al (non-veterans).39
**Hodge et al36; Hodge et al37; Sun et al.49
††Britton et al (males)29; Britton et al (females)29; Guralnik and Kaplan33; Sun et al.49
‡‡Hodge et al36; Hodge et al37; Sun et al.49
Figure 3 Smoking and healthy ageing forest plot.
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example, 1–40 g per day,371–14 drinks per week,381–14 
units per week for women and 1–21 units per week for 
men.46 The one study reporting a negative association 
is that of Willcox et al54; however, this finding should be 
interpreted with caution as drinkers with more than three 
drinks per day are compared with non-drinkers only and 
there is no comparison among light or moderate drinkers 
and non-drinkers. From our meta-analysis, we concluded 
that compared with never drinkers reasonable alcohol 
consumption is beneficial to healthy ageing; pooled OR 
for drinkers 1.28 (95% CI 1.08 to 1.52), light drinkers 
1.12 (95% CI 1.03 to 1.22), moderate drinkers 1.35 
(95% CI 0.93 to 1.97) and high drinkers 1.25 (95% CI 
1.09 to 1.44). Nevertheless, associations are marginally 
statistically significant, while for the moderate category 
the pooled effect estimate is non-significant, so extra 
caution is needed before making a final conclusion.
Several studies of the associations of alcohol consump-
tion with healthy ageing were excluded from our 
meta-analyses; among those there were seven studies that 
reported positive association between alcohol consump-
tion and healthy ageing,38 40 41 44 46 48 50 four studies 
reported non-significant association28 30 52 53 and one 
study reported a negative association.54 As a consequence, 
we expect the positive effect of light to moderate alcohol 
drinking would be reinforced if we included these studies 
in our meta-analyses. This finding comes in accordance 
with the fact that light to moderate alcohol consumption 
(≤1 drink per day) is also associated with a reduced risk of 
multiple cardiovascular outcomes,11 better cognition and 
well-being,58 and a reduced risk of substantial functional 
health decline.59
However, relating moderate alcohol consumption with 
health benefits should not come without question since 
there are many other issues to consider. Our results could 
be biased by confounders that have not been taken into 
account, such as health status or former and occasional 
drinkers to be counted as non-drinkers.60 For instance, in 
the subgroup of drinkers the positive effect comes mainly 
from the study of LaCroix et al39; however, in that study 
former drinkers were also assumed as non-drinkers.
In addition, since typical drink sizes vary per country 
as well as the recommended daily or weekly amounts,61 
we cannot be sure that participants have been assigned 
to the correct drinking category. Our results should also 
be questioned regarding the fact that alcohol consump-
tion was only assessed at baseline (exception to this is 
the study of Sun et al)49; during the baseline assessment 
some cohorts could have had middle-aged participants 
drinking up to four drinks per day and that could be 
considered a moderate consumption. However, older 
people do not have the same tolerance to alcohol62 
and for them moderate consumption should consist 
of up to two drinks per day. Likewise, it should have 
Figure 4 Alcohol and healthy ageing forest plot.
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been considered that older adults tend to consume less 
alcohol than middle-aged groups63 and hence baseline 
assessments perhaps are not representative of alcohol 
consumption in an older age. Nevertheless, more 
research is required to establish or reject the beneficial 
effects of limited alcohol consumption. In an extended 
systematic review and meta-analysis of alcohol impact on 
mortality risk, the benefits of low-volume drinkers largely 
disappeared once studies were controlled for several 
design and methodological issues.64 Mendelian rando-
misation studies, helping to examine causal relation-
ships in observational studies by limiting confounding 
and reverse causation risk of bias,65 may also contribute 
to elucidating if this beneficial effect of light alcohol 
consumption with healthy ageing is a true biological 
effect or not. For instance, a recent study of this type 
found no causal association between alcohol consump-
tion and Alzheimer’s disease.66
strengths and limitations
The fact that this review was independently double 
screened, taking into account previous systematic reviews 
in the field and the reference lists of included papers, 
allows a good amount of confidence that all relevant 
studies were included. Regarding the quality assess-
ment of the studies, limited disagreement among the six 
different domains per study was reached between the two 
reviewers, who independently assessed them, concluding 
that the quality assessment tool was reliable and did not 
allow great amount of misjudgement. Attrition rate and 
not allowing important confounders to be included in the 
final models were important factors contributing to the 
quality of the considered studies. Hence future research 
should consider these domains more thoroughly.
However, the following limitations have to be taken 
into account. Smoking and alcohol consumption were 
not measured or/and defined in a consistent way among 
the different cohorts; hence it was not possible to create 
a pooled effect size estimate across all eligible studies. 
In addition, healthy ageing definition was a source of 
heterogeneity since each study provided its own defi-
nition. Nevertheless, it is noteworthy that all studies 
assumed survival in the follow-up, even if the latter was 
not explicitly mentioned in the healthy ageing defini-
tion, and that many had definitions that included areas 
of physical performance, in agreement with the Depp 
and Jeste review on successful ageing.56 In addition, most 
of the studies used a categorical definition of smoking, 
making impossible the assessment of abstinence time 
or pack-years on healthy ageing. Alcohol measurement 
and drinking categorisation were also another part of 
the underlying heterogeneity. Similar comments have 
been reported in other systematic reviews examining 
alcohol consumption.64 67 Furthermore, self-reported 
questionnaires and the fact that each study was adjusted 
by using a different set of covariates, different follow-up 
time and attrition rate, and the different definition 
of healthy ageing increase the heterogeneity and the 
likelihood of bias. Especially for alcohol, research 
has shown that self-reported consumption is mostly 
underestimated.68
Due to the limited number of studies included in our 
meta-analyses, we did not assess publication bias by funnel 
plots; instead we used Egger test, and even though it was 
statistically non-significant in the majority of cases, we 
applied the trim-and-fill method to examine the robust-
ness of our findings. We used random-effect meta-analysis 
to consider the heterogeneity of the studies, even though 
I2 was not considerable in all analyses (table 3). We did 
not assess heterogeneity with the Cochran’s Q statistic 
due to the quite limited number of studies; performing 
meta-regression analysis and assessing the confounding 
effect of covariates (ie, age, gender, follow-up time) was 
not possible either. However, we did evaluate the robust-
ness of our findings by also implementing the Paule and 
Mandel (PM) estimator to assess between study variability 
and estimate our pooled results as simulations have shown 
that the PM estimator is less biased and more efficient 
than other alternatives.69 We did not observe any consid-
erable fluctuations in our results (online supplementary 
table A3).
We assessed the effect of different baseline age and 
follow-up time to the pooled estimates by performing 
subgroup analyses; pooled effect estimates were not 
severely affected in direction or in strength. The more 
positive effect of non-smoking to studies with relatively 
younger cohorts comes in accordance with other studies 
examining smoking and adverse health outcomes in 
old populations.70 71 When studies incorporate an older 
sample, this is biased in favour of people who smoke 
and survive compared with smokers who die (survival 
bias). Subgroup analyses showed that in studies with 
>65-year-old participants or follow-up time <10 years, the 
beneficial association of former/never compared with 
current smokers with healthy ageing is not statistically 
significant; result which was also indicated by the trim-
and-fill analysis. Follow-up subgroup analysis confirmed 
that the beneficial effect of drinking compared with 
non-drinkers comes from the study of LaCroix et al39 
emphasising that this result should be interpreted with 
caution.
From our review, it is evident that the majority of the 
studies have been implemented in high-income coun-
tries (24 out of 28 studies). Thus, in accordance with 
a previous study,72 our findings revealed the limited 
research on ageing in low-and-middle-income countries 
(LMIC), even though by 2050 80% of people aged ≥60 
years will live there.73 This is of high importance consid-
ering that alcohol use increases in LMICs74 and that 
nowadays 80% of the more than one billion smokers live 
there.75 Estimations also indicate that by 2030 four out of 
five smoking-related deaths will occur there, highlighting 
even more the heavy economic burden of smoking in 
these countries.76
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COnClusIOns
In conclusion, smoking abstinence and smoking cessation 
are positively associated with healthy ageing. As it takes 
>20 years for most smoking-related diseases to develop, 
the best practice would be to enforce smoking preven-
tion policies, such as marketing bans and high taxation, 
and reduce smoking uptake among younger cohorts.1 A 
positive relationship between limited alcohol consump-
tion and healthy ageing could also be argued but more 
research is needed. From our research it becomes evident 
that study designs should be comparable to conclude with 
more confidence the generalisability of our findings. This 
could be achieved by adopting similar measurements of 
smoking and alcohol behaviour and by implementing 
a unanimous metric of healthy ageing. Finally, further 
research should focus on the examination of ageing in 
LMICs.
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